PRESS RELEASE – BLIRT CHANGES OWNERS; 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN

11/05/2022

Gdańsk, 11  May 2022 PRESS RELEASE BLIRT CHANGES OWNERS 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN BLIRT SA, a biotech firm specializing in producing high-quality enzymes and reagents used … Continue reading “PRESS RELEASE – BLIRT CHANGES OWNERS; 96% OF THE COMPANY’S SHARES ACQUIRED BY QIAGEN”

Biotechnology opens up new horizons

06/10/2021

A series about the economic situation of Pomerania – a weekly TV program hosted Vice-President of the Management Board at BLIRT, Tomasz Wrzesiński, who referred to the development of biotechnology: … Continue reading “Biotechnology opens up new horizons”

Expanding Laboratory facilities

Expanding the laboratory facilities

12/08/2021

BLIRT has signed a contract to expand the laboratory facility at Gdansk Science and Technology Park. We produce the highest quality recombinant enzymes and reagents dedicated to the Life Science … Continue reading “Expanding the laboratory facilities”

Are there bacteria in the stratosphere? Check The Stardust project.

29/07/2021

Are there bacteria in the stratosphere? What mechanisms allow them to obtain resistance to high doses of UV and ionizing radiation?    Bartosz Rybacki – our apprentice this year, is … Continue reading “Are there bacteria in the stratosphere? Check The Stardust project.”

ISO 13485 celebration

BLIRT is ISO 13485:2016 certified!

16/06/2021

We are honored to announce that BLIRT has been awarded ISO 13485:2016 Quality Management System certification from Lloyd’s Register. The ISO 13485:2016 certificate covers the entire activity of the company … Continue reading “BLIRT is ISO 13485:2016 certified!”

Blirt became a Registered Exporter

07/04/2021

Blirt has become a registered exporter and received a REX number. The Registered Exporter System (the REX system) is a certification system of origin of goods based on a principle … Continue reading “Blirt became a Registered Exporter”